10-Q Filing

RICH PHARMACEUTICALS, INC. CIK: 1504389 Q2 2012

Filing Information

Form Type	10-Q
Accession Number	`0001255294-12-000764`
Period End Date	20120930
Filing Date	20121106
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	nepa-20120930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 37 Income Statement 43 Cash Flow Statement 39

Balance Sheet 37 line items

Line Item	Tag	Value	Unit	Period
Common Stock, Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Par Value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	90.00M	shares	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.50K	USD	Point-in-time
Cash and equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.50K	USD	Point-in-time
Common Stock, Issued	`CommonStockSharesIssued`	2.62M	shares	Point-in-time
Common Stock, Issued	`CommonStockSharesIssued`	2.62M	shares	Point-in-time
Common Stock, Issued	`CommonStockSharesIssued`	2.62M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	-	USD	Point-in-time
TOTAL ASSETS	`Assets`	$12.50K	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
TOTAL ASSETS	`Assets`	$12.50K	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$5.58K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.58K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	$4.00K	USD	Point-in-time
Due to officer	`DueToOfficersOrStockholdersCurrent`	$9.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$14.58K	USD	Point-in-time
Total Liabilities	`Liabilities`	$10.58K	USD	Point-in-time
Common Stock, $.001 par value, 90,000,000 shares authorized, 2,625,000 shares issued and outstanding	`CommonStockValue`	$2.62K	USD	Point-in-time
Common Stock, $.001 par value, 90,000,000 shares authorized, 2,625,000 shares issued and outstanding	`CommonStockValue`	$2.62K	USD	Point-in-time
Preferred Stock, $.001 par value, 10,000,000 shares authorized, -0- shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred Stock, $.001 par value, 10,000,000 shares authorized, -0- shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$49.88K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$49.88K	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-54.58K	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-50.58K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$1.92K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquity`	$-2.08K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$12.50K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$12.50K	USD	Point-in-time

Income Statement 43 line items

Line Item	Tag	Value	Unit	Period
REVENUES	`Revenues`	-	USD	1 Quarter
REVENUES	`Revenues`	-	USD	9 Qtrs
REVENUES	`Revenues`	-	USD	1 Quarter
REVENUES	`Revenues`	-	USD	2 Qtrs
REVENUES	`Revenues`	-	USD	2 Qtrs
Organization costs	`GeneralAndAdministrativeExpense`	-	USD	2 Qtrs
Organization costs	`GeneralAndAdministrativeExpense`	-	USD	1 Quarter
Organization costs	`GeneralAndAdministrativeExpense`	-	USD	1 Quarter
Organization costs	`GeneralAndAdministrativeExpense`	$320.00	USD	9 Qtrs
Organization costs	`GeneralAndAdministrativeExpense`	-	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$54.26K	USD	9 Qtrs
Professional fees	`ProfessionalFees`	$4.00K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$2.00K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$2.00K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$4.00K	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$4.00K	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$54.58K	USD	9 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$2.00K	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$4.00K	USD	2 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$2.00K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.00K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-54.58K	USD	9 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-4.00K	USD	2 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.00K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-4.00K	USD	2 Qtrs
PROVISION FOR INCOME TAXES	`CurrentIncomeTaxExpenseBenefit`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`CurrentIncomeTaxExpenseBenefit`	-	USD	2 Qtrs
PROVISION FOR INCOME TAXES	`CurrentIncomeTaxExpenseBenefit`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`CurrentIncomeTaxExpenseBenefit`	-	USD	9 Qtrs
PROVISION FOR INCOME TAXES	`CurrentIncomeTaxExpenseBenefit`	-	USD	2 Qtrs
NET LOSS	`IncomeLossFromContinuingOperations`	$-4.00K	USD	2 Qtrs
NET LOSS	`IncomeLossFromContinuingOperations`	$-4.00K	USD	2 Qtrs
NET LOSS	`IncomeLossFromContinuingOperations`	$-54.58K	USD	9 Qtrs
NET LOSS	`IncomeLossFromContinuingOperations`	$-2.00K	USD	1 Quarter
NET LOSS	`IncomeLossFromContinuingOperations`	$-2.00K	USD	1 Quarter
NET LOSS PER SHARE: BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
NET LOSS PER SHARE: BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
NET LOSS PER SHARE: BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
NET LOSS PER SHARE: BASIC AND DILUTED	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	`WeightedAverageNumberOfSharesOutstandingBasicDiluted`	2.62M	shares	2 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	`WeightedAverageNumberOfSharesOutstandingBasicDiluted`	2.62M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	`WeightedAverageNumberOfSharesOutstandingBasicDiluted`	2.62M	shares	2 Qtrs
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	`WeightedAverageNumberOfSharesOutstandingBasicDiluted`	2.62M	shares	1 Quarter

Cash Flow Statement 39 line items

Line Item	Tag	Value	Unit	Period
Net loss for the period	`ProfitLoss`	$-4.00K	USD	2 Qtrs
Net loss for the period	`ProfitLoss`	$-54.58K	USD	9 Qtrs
Net loss for the period	`ProfitLoss`	$-4.00K	USD	2 Qtrs
(Increase) decrease in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	9 Qtrs
(Increase) decrease in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.00K	USD	2 Qtrs
(Increase) decrease in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	2 Qtrs
Increase (decrease) in accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$5.58K	USD	9 Qtrs
Increase (decrease) in accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.00K	USD	2 Qtrs
Increase (decrease) in accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	-	USD	2 Qtrs
Net Cash Used by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.00K	USD	2 Qtrs
Net Cash Used by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-49.00K	USD	9 Qtrs
Net Cash Used by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	-	USD	2 Qtrs
Increase in due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	2 Qtrs
Increase in due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	$9.00K	USD	9 Qtrs
Increase in due to officer	`IncreaseDecreaseInDueToOfficersAndStockholders`	$5.00K	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOrSaleOfEquity`	$52.50K	USD	9 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOrSaleOfEquity`	$52.50K	USD	Point-in-time
Proceeds from sale of common stock	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOrSaleOfEquity`	-	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$61.50K	USD	9 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$5.00K	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashPeriodIncreaseDecrease`	-	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashPeriodIncreaseDecrease`	-	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`CashPeriodIncreaseDecrease`	$12.50K	USD	9 Qtrs
Cash and cash equivalents, beginning of period	`Cash`	$29.81K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`Cash`	$12.50K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`Cash`	$29.81K	USD	Point-in-time
Cash and cash equivalents, beginning of period	`Cash`	-	USD	Point-in-time
Cash and cash equivalents, beginning of period	`Cash`	$12.50K	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	$29.81K	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	$12.50K	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	$29.81K	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	-	USD	Point-in-time
Cash and cash equivalents, end of period	`Cash`	$12.50K	USD	Point-in-time
Interest paid	`InterestPaid`	-	USD	2 Qtrs
Interest paid	`InterestPaid`	-	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	-	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaid`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.